<DOC>
	<DOCNO>NCT00895804</DOCNO>
	<brief_summary>MDMA ( 3,4-Methylenedioxymethamphetamine , `` Ecstasy '' ) produce tachycardia , hypertension , hyperthermia , acute adverse effect . Ecstasy use also associate rare cardio- cerebrovascular complication . The role beta-blockers treatment cardiovascular adverse effect MDMA unknown .</brief_summary>
	<brief_title>Pharmacological Interaction Between Pindolol MDMA ( 3,4-Methylenedioxymethamphetamine )</brief_title>
	<detailed_description>We investigate interactive effect beta-blocker pindolol ( 20 mg ) MDMA ( 1.6 mg/kg ) heart rate , blood pressure , body temperature , adverse effect double-blind placebo-controlled study 16 healthy subject .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>N-Methyl-3,4-methylenedioxyamphetamine</mesh_term>
	<mesh_term>Pindolol</mesh_term>
	<criteria>Sufficient understanding German language Subjects understand procedure risk associate study Participants must willing adhere protocol sign consent form Participants must willing refrain take illicit psychoactive substance study . Participants must willing drink alcoholfree liquid xanthinecontaining liquid midnight even study session . Participants must willing drive traffic vehicle even study day . Body mass index : 1825 kg/m2 Chronic acute medical condition include clinically relevant abnormality physical exam , laboratory value , ECG . In particular : Hypertension ( &gt; 140/90 mmHg ) . Personal firstgrade history seizure . Cardiac neurological disorder . Current previous psychotic affective disorder Psychotic affective disorder firstdegree relatives Prior illicit drug use ( except THCcontaining product ) 5 time time within previous 2 month . Participation another clinical trial ( currently within last 30 day ) Use medication contraindicate otherwise interfere effect study medication .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>MDMA</keyword>
	<keyword>beta adrenergic</keyword>
	<keyword>Ecstasy</keyword>
</DOC>